/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

T

Tri Tat

Debiopharm (Switzerland)(CH)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

11

Papers

838

Citations

7

h-index

5

i10-index

Tri Tat is an academic researcher from Debiopharm (Switzerland). The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies. The author has an h-index of 7, co-authored 10 publications.

ORCID: 0009-0004-6837-8277

Research Topics

HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Pulmonary Hypertension Research and Treatments Cancer therapeutics and mechanisms

Papers by this author

works

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)

2012 · Annals of Oncology · 17 citations

https://doi.org/10.1093/annonc/mds594

R. Charles Coombes Tri Tat Marie Miller J.A. Reise

Research topics

topics

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Breast Cancer Treatment Studies

Pulmonary Hypertension Research and Treatments

Cancer therapeutics and mechanisms

Chat about Author

Papers

Chat

Click to start Chat